Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

View up-to-date information on MorphoSys AG patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
RS64746B1 Grant Treatment paradigm for an anti-cd19 antibody and venetoclax combination treatment A61K2039/505; A61K2039/545; A61K2300/00; A61K31/496; A61K31/635; A61K39/395; A61K39/3955; A61K45/06; A61P35/00; C07K16/2803 November 30, 2023
AU2022271834A1 Application Use of pelabresib for treating anemias A61K31/519; A61K31/55; A61K45/06; A61P7/06 November 30, 2023
AU2022202796B2 Grant Combination of an anti-cd19 antibody and a bruton's tyrosine kinase inhibitor and uses thereof A61K2039/505; A61K2300/00; A61K31/519; A61K39/3955; A61K39/39558; A61K45/06; A61K47/68; A61P35/00; A61P35/02; C07K16/2803; C07K16/2896; C07K2317/24; C07K2317/732 November 23, 2023
EP4277930A1 Application Anti-cd38-antikörper und deren verwendungen A61P13/12; C07K16/2896; C07K2317/21 November 22, 2023
CN112218857B Grant P300/cbp hat抑制剂及其使用方法 A61K45/06; A61P11/00; A61P29/00; A61P3/00; A61P31/12; A61P35/00; A61P9/00; C07D209/08; C07D211/32; C07D213/75; C07D215/08; C07D231/12; C07D231/40; C07D233/64; C07D237/08; C07D239/26; C07D241/04; C07D295/135; C07D401/04; C07D401/14; C07D403/04; C07D405/04; C07D413/04; C07D417/04; C07D487/04; C07D491/107 November 21, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Register your interest

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer